Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Borg, JY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 51 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lepercq, J; Conard, J; Borel-Derlon, A; Darmon, JY; Boudignat, O; Francoual, C; Priollet, P; Cohen, C; Yvelin, N; Schved, JF; Tournaire, M; Borg, JY
      Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    2. Neerman-Arbez, M; de Moerloose, P; Honsberger, A; Parlier, G; Arnuti, B; Biron, C; Borg, JY; Eber, S; Meili, E; Peter-Salonen, K; Ripoll, L; Vervel, C; d'Oiron, R; Staeger, P; Antonarakis, SE; Morris, MA
      Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes

      HUMAN GENETICS
    3. Le Querrec, A; Arnout, J; Arnoux, D; Borg, JY; Caron, C; Darnige, L; Delahousse, B; Reber, G; Sie, P
      Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies

      THROMBOSIS AND HAEMOSTASIS
    4. Levesque, H; Borg, JY; Bossi, P; Goudemand, J; Guillet, B; Cabane, J
      Acquired haemophilia: diagnosis and therapeutic management.

      REVUE DE MEDECINE INTERNE
    5. Vasse, M; Massardier, EG; Borg, JY; Woimont, F; Soria, C
      Frequency of protein Z deficiency in patients with ischaemic stroke - Reply

      LANCET
    6. Vasse, M; Guegan-Massardier, E; Borg, JY; Woimant, F; Soria, C
      Frequency of protein Z deficiency in patients with ischaemic stroke

      LANCET
    7. Guedon, C; Le Cam-Duchez, V; Lalaude, O; Menard, JF; Lerebours, E; Borg, JY
      Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    8. Aillaud, MF; Morange, P; Juhan, I; Bauters, A; Jude, B; Biron-Andreani, C; Daures, JP; Schved, JF; Pernod, G; Polac, B; Bridey, F; De Prost, D; Borg, JY; Saladin-Theron, C; Le Cam, V; Denninger, MH; Truchaud, F; Trossaert, M; Boinot, C; Sultan, Y; Delahousse, B; Fimbel, B; Gruel, Y; Houbouyan, L; Bihour, C; Vergnes, C; Dutrillaux, F; Lorenzini, JL; Julia, A; Deschamps, A; Favier, R; Freyburger, G; Trzeciak, MC; Berruyer, M; Doumergue, G; Gris, JC; Toulon, P; Montpied, G; Marques-Verdier, A; Lequerrec, A; Guerin, V; Massignon, D
      Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study

      BLOOD COAGULATION & FIBRINOLYSIS
    9. Marie, I; Levesque, H; Lecam-Duchez, V; Borg, JY; Ducrotte, P; Philippe, C
      Mesenteric venous thrombosis revealing both factor II G20210A mutation andhyperhomocysteinemia related to pernicious anemia

      GASTROENTEROLOGY
    10. Verspyck, E; Le Cam-Duchez, V; Gravier, A; Descargues, G; Marpeau, L; Borg, JY
      Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A)

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    11. Le Cam-Duchez, V; Gandrille, S; Tregouet, D; Alhenc-Gelas, M; Emmerich, J; Fiessinger, JN; Borg, JY; Aiach, M
      Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor VArg 506 to Gln mutation

      BRITISH JOURNAL OF HAEMATOLOGY
    12. Pouplard, C; Amiral, J; Borg, JY; Laporte-Simitsidis, S; Delahousse, B; Gruel, Y
      Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia

      AJCP. American journal of clinical pathology
    13. GUEDON C; BORG JY; LALAUDE O; LECAMDUCHEZ V; PHILIPPE C; LEREBOURS E; COLIN R
      ENHANCED PROCOAGULANT ACTIVITY IN ACUTE CROHNS-DISEASE (CD)

      Gastroenterology
    14. LEVESQUE H; BORG JY; COURTOIS H
      THE VASCULAR RISK OF 3RD-GENERATION ORAL- CONTRACEPTIVES

      Journal des maladies vasculaires
    15. BORG JY; LEVESQUE H; CAILLEUX N; FRANC C; HELLOT MF; COURTOIS H
      RAPID QUANTITATIVE D-DIMER ASSAY AND CLINICAL-EVALUATION FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP-VEIN THROMBOSIS

      Thrombosis and haemostasis
    16. GOUDEMAND J; CARON C; DEPROST D; DERLON A; BORG JY; SAMPOL J; SIE P
      EVALUATION OF SENSITIVITY AND SPECIFICITY OF A STANDARDIZED PROCEDUREUSING DIFFERENT REAGENTS FOR THE DETECTION OF LUPUS ANTICOAGULANTS

      Thrombosis and haemostasis
    17. BORG JY; YASTREMSKY F; DESHAYES A; TOULLEC J; CHRETIEN MH; VASSE M; SALADINTHIRON C; FREBOURG T
      RELIABLE IDENTIFICATION OF FACTOR-V-LEIDEN INDIVIDUALS BY MODIFIED APC RESISTANCE TESTS

      Thrombosis and haemostasis
    18. LECAMDUCHEZ V; GANDRILLE S; ALHENCGELAS M; EMMERICH J; BORG JY; AIACH M
      ADDITIONAL GENETIC RISK-FACTORS FOR THROMBOSIS IN 21 FAMILIES CARRYING THE FACTOR-V ARG-506 TO GLN MUTATION

      Thrombosis and haemostasis
    19. BORG JY; DURIEZ D; THIRION C; NICHAM F; PERRY DJ; CARRELL RW
      IMPROVEMENT IN THE IDENTIFICATION OF ANTITHROMBIN DEFICIENT PATIENTS

      Thrombosis and haemostasis
    20. POUPLARD C; AMIRAL J; BORG JY; VISSAC AM; DELAHOUSSE B; REVERDIAUMOALIC P; GRUEL Y
      DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN

      Thrombosis and haemostasis
    21. AILLAUD MF; JUHAN I; BAUTERS A; JUDE B; BIRON C; SCHVED JF; PERNOD G; POLACK B; DELAHOUSSE B; FIMBEL B; MARQUESVERDIER A; BRIDEY F; TRUCHAUD F; TROSSAERT M; BIHOUR C; VERGNES C; GRIS JC; DENNINGER MH; DUTRILLAUX F; LORENZINI JL; HOUBOUYAN L; LEQUERREC A; FREYBURGER G; BORG JY; BOINOT C; SULTAN Y; TREZIACK MC; BERRUYER M; GUERIN V; TOULON P; MASSIGNON D; DESCHAMPS A; FAVIER R; ROBERT A; JULIA A
      CLINICAL AND BIOLOGICAL DATA IN 68 SUBJECTS WITH HOMOZYGOUS R506Q MUTATION - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY

      Thrombosis and haemostasis
    22. POUPLARD C; AMIRAL J; BORG JY; VISSAC AM; DELAHOUSSE B; GRUEL Y
      DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED IN HEPARIN-INDUCED THROMBOCYTOPENIA AND CONSEQUENCES ON CROSS-REACTIVITY WITH DANAPAROID SODIUM

      British Journal of Haematology
    23. ALHENCGELAS M; LECAMDUCHEZ V; EMMERICH J; FREBOURG T; FIESSINGER JN; BORG JY; AIACH M
      THE A20210-ALLELE OF THE PROTHROMBIN GENE IS NOT FREQUENTLY ASSOCIATED WITH THE FACTOR-V-ARG-506-TO-GLN-MUTATION IN THROMBOPHILIC FAMILIES

      Blood
    24. BIRON C; SCHVED JF; AILLAUD MF; JUHAN I; BAUTERS A; JUDE B; PERNOD G; POLACK B; BRIDEY F; DEPROST D; BORG JY; SALADIN C; LECAM V; DENNINGER MH; TRUCHAUD F; TROSSAERT M; BOINOT C; SULTAN Y; DELAHOUSSE B; FIMBEL B; GRUEL Y; HOUBOUYAN L; BIHOUR C; VERGNES C; DUTRILLAUX F; LORENZINI JL; JULIA A; DESCHAMPS A; FAVIER R; FREYBURGER G; TREZIACK MC; BERRUYER M; GRIS JC; TOULON P; MARQUESVERDIER A; LEQUERREC A; GUERIN V; MASSIGNON D
      CLINICAL AND BIOLOGICAL DATA IN 85-R506Q HOMOZYGOTES - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY

      Blood
    25. MARIE I; LEVESQUE H; HERON F; CAILLEUX N; BORG JY; COURTOIS H
      ACUTE ADRENAL FAILURE SECONDARY TO BILATERAL INFARCTION OF THE ADRENAL-GLANDS AS THE FIRST MANIFESTATION OF PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME

      Annals of the Rheumatic Diseases
    26. SCHLEIFER DM; CHASSAING S; CARON F; BORG JY; BOUCHART F; SOYER R
      CALCIUM HEPARIN-INDUCED HYPEREOSINOPHILIA

      La Presse medicale
    27. BOUANICHE M; GUEDON C; BORG JY; ZALAR A; DUCROTTE P; LEREBOURS E
      ANTIPHOSPHOLIPID SYNDROME AS A CAUSE OF P ORTAL-VEIN THROMBOSIS - 2 CASES

      Gastroenterologie clinique et biologique
    28. CAILLEUX N; LEVESQUE H; COURTOIS H; BORG JY
      ACQUIRED ANTI-VIII ANTIBODIES - A NEW CAS E

      Journal des maladies vasculaires
    29. CAILLEUX N; GUEGANMASSARDIER E; BORG JY; VASSE M; MIHOUT B; WATELET J; LEVESQUE H; COURTOIS H
      PSEUDOTHROMBOANGIITIS OBLITERANS AND QUAL ITATIVE PROTEIN-C DEFECT - A CASE-REPORT

      Journal des maladies vasculaires
    30. DUCHEMIN J; BORG JY; BORGEL D; VASSE M; LEVEQUE H; AIACH M; GANDRILLE S
      5 NOVEL MUTATIONS OF THE PROTEIN-S ACTIVE GENE (PROS-1) IN 8 NORMAN FAMILIES

      Thrombosis and haemostasis
    31. BORG JY; MARTEL P; KERLEAU JM; LEFEBVRE H; WOLF LM
      ASSOCIATION OF PRIMARY ANTIPHOSPHOLIPID S YNDROME AND ANTITHROMBIN-III DEFICIENCY IN A PATIENT WITH CEREBRAL INFARCTION - A FIRST CASE

      La Revue de medecine interne
    32. MATHONNET F; DEMAZANCOURT P; BASTENAIRE B; MOROT M; BENATTAR N; BEUFE S; BORG JY; GIUDICELLI Y
      ACTIVATED PROTEIN-C SENSITIVITY RATIO IN PREGNANT-WOMEN AT DELIVERY

      British Journal of Haematology
    33. BIRON C; SCHVED HF; AILLAUD MF; JUHAN I; BAUTERS A; JUDE B; PERNOD G; POLACK B; DELAHOUSSE B; FIMBEL B; MARQUESVERDIER A; BRIDEY F; TRUCHAUD F; TROSSAERT M; BIHOUR C; VERGNES C; GRIS JC; DENNINGER MH; DUTRILLAUX F; LORENZINI JL; HOUBOUYAN L; LEQUERREC A; FREYBURGER G; BORG JY; BOINOT C; SULTAN Y; TREZIACK MC; BERURRIER M; GUERIN V; TOULON P; MASSIGNON D; DESCHAMPS A; FAVIER R; JULIA A
      FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - THE PROCARE STUDY

      Blood
    34. BORG JY
      CAN LOW-MOLECULAR-WEIGHT HEPARIN BE USED IN PREGNANT-WOMEN

      Annales de medecine interne
    35. PERRY DJ; MARSHALL C; BORG JY; TAIT RC; DALY ME; WALKER ID; CARRELL RW
      2 NOVEL ANTITHROMBIN VARIANTS, ASN187ASP AND ASN187LYS, INDICATE A FUNCTIONAL-ROLE FOR ASPARAGINE 187

      Blood coagulation & fibrinolysis
    36. VASSE M; GAUCHER C; BEUFE S; VANDREDEN P; MONCONDUIT M; MAZURIER C; BORG JY; SORIA C
      ANALYSIS OF FACTOR-VIII IN A FAMILY WITH INHERITED RESISTANCE TO ACTIVATED PROTEIN-C WITHOUT FACTOR-V LEYDEN

      Thrombosis and haemostasis
    37. VOISIN L; DERUMEAUX G; BORG JY; MEJJAD O; VITTECOQ O; TAYOT J; THOMINE E; TRON F; LELOET X
      CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WITH FATAL ACUTE COURSE IN RHEUMATOID-ARTHRITIS

      Journal of rheumatology
    38. BEUFE S; BORG JY; VASSE M; CHARBONNIER F; MOREAU V; MONCONDUIT M; FREBOURG T
      CO-SEGREGATION OF THROMBOSIS WITH THE FACTOR-V Q506 MUTATION IN AN EXTENDED FAMILY WITH RESISTANCE TO ACTIVATED PROTEIN-C

      British Journal of Haematology
    39. LAIR G; JOLY P; BORG JY; LEFEBVRE H; SURLEMONT Y; LAURET P
      PROTEIN-S DEFICIENCY IN A PATIENT WITH NE CROTIZING CELLULITIS OF THEPENIS

      Annales de dermatologie et de venereologie
    40. VASSE M; LEDUC O; BORG JY; CHRETIEN MH; MONCONDUIT M
      RESISTANCE TO ACTIVATED PROTEIN-C - EVALUATION OF 3 FUNCTIONAL ASSAYS

      Thrombosis research
    41. LEVESQUE H; CAILLEUX N; VASSE D; LEGALLICIER B; MOORE N; BORG JY; HANTUTE N; THUILLEZ C; COURTOIS H
      COST EVALUATION OF TREATMENT OF DEEP-VEIN THROMBOSIS (ON 6 DAYS) - COMPARISON NADROPARIN AND INTRAVENOUS HEPARIN IN 40 HOSPITALIZED-PATIENTS

      Therapie
    42. NGUYEN P; LECOMPTE T; DIEVAL J; GROSS S; FRESSINAUD E; DENNIGER MH; BRIDEY F; ECLACHE V; AUROUSSEAU MC; FIALON P; HOUBOUYAN L; BLOUCH MT; MASSONETCASTEL S; LEQUERREC A; BEZOU MJ; MARQUESVERDIER A; TOULON P; DARNIGE L; GOUAULTHEILMANN M; DUTRILLAUX F; GUINARD S; LORENZINI JL; DEMOERLOOSE P; PERNOD G; DERAUCOURT E; BELLUCCI S; MAZOYER E; DOUBINE S; CARON C; JUDE B; WATEL A; HANSS M; AILLAUD MF; ARNOUX D; BIRON C; JUNG G; ALEXANDRE P; BRIQUEL E; GRIS JC; NURDEN P; VERGNES C; BOINOT C; POMMEREUIL M; DESCHAMPS A; BORG JY; HOMBERG JC; FRANCOIS D; VERDY E; GRUEL Y; SIE P
      HEPARIN-INDUCED THROMBOCYTOPENIA - A SURVEY OF TESTS EMPLOYED AND ATTITUDES IN HEMATOLOGY LABORATORIES

      Nouvelle revue francaise d'hematologie
    43. BRUCE D; PERRY DJ; BORG JY; CARRELL RW; WARDELL MR
      THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP)

      The Journal of clinical investigation
    44. ALEXANDRE P; AMIRAL J; BIENVENU J; BORG JY; BRIDEY F; CAHAN L; COMBE S; DELAHOUSSE B; DREYFUS M; GAUTHIER C; JUHANVAGUE I; LANDAUER D; MUSITELLI JJ; POUZOL P; RAISKY F; REYNAUD J; SIE P; SITBON O; TREZIAC MC
      MARKERS OF HEMOSTATIC SYSTEM ACTIVATION IN ACUTE DEEP VENOUS THROMBOSIS-EVOLUTION DURING THE FIRST DAYS OF HEPARIN TREATMENT

      Thrombosis and haemostasis
    45. AIACH M; AILLAUD MF; ALHENCGELAS M; BORG JY; BOUTIERES B; CONTANT G; DELAHOUSE B; DERLON A; HOUBOUYAN L; JUHAN I; DEMOERLOOSE P; POLAK B; POUZOL P; DEPROST D; LEQUERREC A; REBER G; SAMPOL J; SCROBOHACCI ML; SIE P; VERDY E
      COMPARISON OF A STANDARDIZED PROCEDURE WITH CURRENT LABORATORY PRACTICES FOR THE DETECTION OF LUPUS ANTICOAGULANT IN FRANCE

      Thrombosis and haemostasis
    46. BORG JY; VASSE M; LEVESQUE H; QUEDINEL V; ARZUR C; DALIPHARD S; CHRETIEN MH; DUCLOS M; THIRON C
      LONG-TERM MANAGEMENT OF ORAL ANTICOAGULANT-THERAPY IN CONGENITAL QUANTITATIVE PROTEIN-S OR PROTEIN-C DEFICIENCY USING BIOLOGICAL PRETHROMBOTIC MARKERS

      Thrombosis and haemostasis
    47. BORG JY; LEVESQUE H; VASSE M; DALIPHARD S; CAILLEUX N; MONCONDUIT M; COURTOIS H
      ACQUIRED VON-WILLEBRAND SYNDROME DURING HYPOTHYROIDISM - EFFECTS OF THYROXINE TREATMENT ON VON-WILLEBRAND-FACTOR AND FIBRINOLYSIS PARAMETERS

      Thrombosis and haemostasis
    48. BORG JY; CHRETIEN MH; DOUCET J; BERCOFF E; CHEMINOT N; AZOULAY S; VASSE M; CHRETIEN P
      PHARMACOKINETIC AND HEMOSTATIC EFFECTS OF DERMATAN SULFATE (DS, MEDIOLANUM-PHARMACEUTICI) ADMINISTERED BY INTRAVENOUS-INFUSION IN ELDERLY VOLUNTEERS

      Thrombosis and haemostasis
    49. LEVESQUE H; BORG JY; CAILLEUX N; TRON F; VASSE M; MEJJAD O; OMNIENT Y; DERUMEAUX G; ETIENNE I; MIHOUT B; TESTART J; GODIN M; LELOET X; BRASSEUR G; COURTOIS H
      SIGNS OF ARTERIAL THROMBOSIS IN ANTIPHOSP HOLIPID SYNDROME - REPORT ON 155 CASES

      La Revue de medecine interne
    50. FIKSSIGAUD M; BENDELAC L; PARQUET A; VERROUST F; TORCHET MF; BERTHIER AM; FRESSINAUD E; GUEROIS C; AILLAUD MF; BONEU B; DERLON A; SUBTIL E; BERTRAND MA; BORG JY; LAURIAN Y
      COMPARISON OF ANTI-HUMAN AND ANTIPORCINE FACTOR-VIII INHIBITOR LEVELSIN 63 PATIENTS WITH SEVERE HEMOPHILIA-A

      Vox sanguinis
    51. CARRELL RW; BRUCE D; BORG JY; WARDELL M
      MECHANISM OF HEPARIN ACTIVATION OF ANTITHROMBIN - EVIDENCE FROM 2 HIGH-AFFINITY VARIANTS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 12:22:37